Carlisle Companies Incorporated (CSL)

Net profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands 1,311,800 767,400 924,000 421,700 320,100
Revenue US$ in thousands 5,003,600 4,586,900 6,591,900 4,810,300 3,969,900
Net profit margin 26.22% 16.73% 14.02% 8.77% 8.06%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $1,311,800K ÷ $5,003,600K
= 26.22%

The net profit margin of Carlisle Companies Incorporated has displayed a positive trend over the past five years. In December 31, 2020, the net profit margin stood at 8.06%, showing a modest profitability level. Subsequently, in December 31, 2021, the net profit margin improved to 8.77%, indicating a slight increase in profitability.

A more significant improvement was observed in December 31, 2022, with the net profit margin soaring to 14.02%, reflecting a substantial enhancement in the company's profitability. This positive trajectory continued in December 31, 2023, as the net profit margin further rose to 16.73%, underlining a continued growth in profitability.

The most notable increase in profitability was recorded in December 31, 2024, with the net profit margin reaching 26.22%. This remarkable surge indicates a substantial boost in the company's ability to convert revenue into net income, showcasing a strong performance.

Overall, the trend of increasing net profit margins reflects Carlisle Companies' effective cost management, revenue growth, or both, contributing to enhanced profitability and potentially indicating a healthy financial position for the company.


Peer comparison

Dec 31, 2024

Company name
Symbol
Net profit margin
Carlisle Companies Incorporated
CSL
26.22%
West Pharmaceutical Services Inc
WST
17.03%